Considering the biology of late recurrences in selecting patients for extended endocrine therapy in breast cancer-Reference-Cited by-同舟云学术

Considering the biology of late recurrences in selecting patients for extended endocrine therapy in breast cancer

Published:2018-11 Issue: Volume:70 Page:118-126
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Bense Rico D.,Qiu Si-Qi,de Vries Elisabeth G.E.,Schröder Carolien P.,Fehrmann Rudolf S.N.

Funder

Dutch Cancer Society

NWO-VENI

Mandema Stipendium of the University Medical Center Groningen

Graduate School of Medical Sciences of the University Medical Center Groningen

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Reference68 articles.

1. Annual hazard rates of recurrence for breast cancer during 24 years of follow-up: results from the International Breast Cancer Study Group Trials I to V;Colleoni;J Clin Oncol,2016

2. 20-year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years;Pan;N Engl J Med,2017

3. Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial;Davies;Lancet,2013

4. aTTom: long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years in 6,953 women with early breast cancer;Gray;J Clin Oncol,2013

5. Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17;Goss;J Natl Cancer Inst,2005

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a Prognostic Model for HR-positive HER2-negative and Node-negative Breast Cancer: Integrating Clinical and Transcriptional Biomarkers;2024-05-24

2. Donors risk assessment in transplantation: From the guidelines to their real-world application;Pathology - Research and Practice;2024-03

3. Detection of Cellular Senescence Reveals the Existence of Senescent Tumor Cells within Invasive Breast Carcinomas and Related Metastases;Cancers;2023-03-20

4. Baicalein resensitizes tamoxifen‐resistant breast cancer cells by reducing aerobic glycolysis and reversing mitochondrial dysfunction via inhibition of hypoxia‐inducible factor‐1α;Clinical and Translational Medicine;2021-11

5. Hypofractionated Radiation Therapy (HFRT) of Breast/Chest Wall and Regional Nodes in Locally Advanced Breast Cancer: Toxicity Profile and Survival Outcomes in Retrospective Mono-Institutional Study: In Regard to De Matteis et al;Clinical Breast Cancer;2021-10